Suneel Gupta

Track

Insider profile

Currently holds a position at Protagonist Therapeutics Inc

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return 14% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Development Officer Protagonist Therapeutics Inc May 8, 2019 -
Executive Vice President of Clinical Operations and Clinical Pharmacology Protagonist Therapeutics Inc Jan. 7, 2019 - May 8, 2019
Suneel Gupta's trades of Protagonist Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
441.74
Quantity 6,060
Value US$4,397,751
Transaction date
Proposed sale
Price
46.46
Quantity 103,437
Value US$4,805,683
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-27 2024-11-26
S Sale
90,533 +31.7%
281.49
US$2,435,895 		90,533 +31.7% 281.49 US$2,435,895
2024-11-26 2024-11-26
PrS Proposed sale
6,060
441.74
US$4,397,751 		6,060 441.74 US$4,397,751
2024-11-27 2024-11-25
S Sale
64,475 -9.0%
389.99
US$4,715,432 		64,475 -9.0% 389.99 US$4,715,432
2024-11-25 2024-11-25
PrS Proposed sale
103,437
46.46
US$4,805,683 		103,437 46.46 US$4,805,683
2024-01-11 2024-01-09
PlS Planned sale
5,000 -2.6%
25.00
US$125,000 		5,000 -2.6% 25.00 US$125,000
2024-01-09 2024-01-09
PrS Proposed sale
5,000
25.00
US$125,000 		5,000 25.00 US$125,000